746 related articles for article (PubMed ID: 27526874)
1. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.
Cadete A; Alonso MJ
Nanomedicine (Lond); 2016 Sep; 11(17):2341-57. PubMed ID: 27526874
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle approaches to combating drug resistance.
Moon JH; Moxley JW; Zhang P; Cui H
Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
[TBL] [Abstract][Full Text] [Related]
3. Ligand-Installed Nanocarriers toward Precision Therapy.
Mi P; Cabral H; Kataoka K
Adv Mater; 2020 Apr; 32(13):e1902604. PubMed ID: 31353770
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents.
Jia F; Liu X; Li L; Mallapragada S; Narasimhan B; Wang Q
J Control Release; 2013 Dec; 172(3):1020-34. PubMed ID: 24140748
[TBL] [Abstract][Full Text] [Related]
5. Prodrugs in combination with nanocarriers as a strategy for promoting antitumoral efficiency.
Lin MH; Hung CF; Hsu CY; Lin ZC; Fang JY
Future Med Chem; 2019 Aug; 11(16):2131-2150. PubMed ID: 31538520
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured hyaluronic acid-based materials for active delivery to cancer.
Ossipov DA
Expert Opin Drug Deliv; 2010 Jun; 7(6):681-703. PubMed ID: 20367530
[TBL] [Abstract][Full Text] [Related]
7. Gold nanoparticle mediated cancer immunotherapy.
Almeida JP; Figueroa ER; Drezek RA
Nanomedicine; 2014 Apr; 10(3):503-14. PubMed ID: 24103304
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy.
Wickens JM; Alsaab HO; Kesharwani P; Bhise K; Amin MCIM; Tekade RK; Gupta U; Iyer AK
Drug Discov Today; 2017 Apr; 22(4):665-680. PubMed ID: 28017836
[TBL] [Abstract][Full Text] [Related]
9. Evaluating Nanomedicines: Obstacles and Advancements.
Swierczewska M; Crist RM; McNeil SE
Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
[TBL] [Abstract][Full Text] [Related]
10. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid for anticancer drug and nucleic acid delivery.
Dosio F; Arpicco S; Stella B; Fattal E
Adv Drug Deliv Rev; 2016 Feb; 97():204-36. PubMed ID: 26592477
[TBL] [Abstract][Full Text] [Related]
12. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
Huang D; He B; Mi P
Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
[TBL] [Abstract][Full Text] [Related]
13. [Hyaluronic acid-based carriers for tumor targeted delivery system].
Qiu LP; Long MM; Chen DW
Yao Xue Xue Bao; 2013 Sep; 48(9):1376-82. PubMed ID: 24358769
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy.
Gao M; Deng H; Zhang W
Curr Top Med Chem; 2021; 21(2):126-139. PubMed ID: 32962617
[TBL] [Abstract][Full Text] [Related]
15. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
16. Nanoscaled boron-containing delivery systems and therapeutic agents for cancer treatment.
Wang J; Wu W; Jiang X
Nanomedicine (Lond); 2015; 10(7):1149-63. PubMed ID: 25929571
[TBL] [Abstract][Full Text] [Related]
17. Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery.
Chen Z; Li Z; Lin Y; Yin M; Ren J; Qu X
Chemistry; 2013 Jan; 19(5):1778-83. PubMed ID: 23303570
[TBL] [Abstract][Full Text] [Related]
18. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
[TBL] [Abstract][Full Text] [Related]
19. Design of multifunctional nanocarriers for delivery of anti-cancer therapy.
Mehra NK; Jain K; Jain NK
Curr Pharm Des; 2015; 21(42):6157-64. PubMed ID: 26503145
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronate-Lipid Nanohybrids: Fruitful Harmony in Cancer Targeting.
Freag MS
Curr Pharm Des; 2017; 23(35):5283-5291. PubMed ID: 28552066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
